(S)-2-acetamido-6-amino-N-((2S,3S)-1-(((2S,3R)-1-(((S)-1-(((S)-1-(cyclopropylamino)-1,2-dioxopentan-3-yl)amino)-1-oxopropan-2-yl)amino)-3-hydroxy-1-oxobutan-2-yl)amino)-3-methyl-1-oxopentan-2-yl)hexanamide Hydrochloride

ID: ALA5205624

PubChem CID: 168296005

Max Phase: Preclinical

Molecular Formula: C29H52ClN7O8

Molecular Weight: 625.77

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CC[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(C)=O)[C@@H](C)CC)[C@@H](C)O)C(=O)C(=O)NC1CC1.Cl

Standard InChI:  InChI=1S/C29H51N7O8.ClH/c1-7-15(3)22(35-26(41)21(32-18(6)38)11-9-10-14-30)27(42)36-23(17(5)37)28(43)31-16(4)25(40)34-20(8-2)24(39)29(44)33-19-12-13-19;/h15-17,19-23,37H,7-14,30H2,1-6H3,(H,31,43)(H,32,38)(H,33,44)(H,34,40)(H,35,41)(H,36,42);1H/t15-,16-,17+,20-,21-,22-,23-;/m0./s1

Standard InChI Key:  RGVLEAIBFYBMTD-PEFJUNQQSA-N

Molfile:  

     RDKit          2D

 45 44  0  0  0  0  0  0  0  0999 V2000
    5.9398   -1.9629    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -5.0577    0.4126    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3432    0.8251    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0577   -0.4125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3430   -0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3430   -1.6503    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6284   -2.0629    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6284   -2.8881    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7724    0.8253    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4870    0.4126    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.2015    0.8253    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4870   -0.4125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3432    1.6504    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6286    0.4125    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9140    0.8251    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1993    0.4125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9140    1.6504    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6286    2.0629    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1993    2.0629    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6286    2.8881    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4846    0.8251    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1993   -0.4126    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7700    0.4125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0553    0.8251    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7700   -0.4126    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0553   -0.8252    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4846   -0.8252    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0553    1.6504    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.6592    0.4125    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.3738    0.8251    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0884    0.4125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3738    1.6504    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8032    0.8251    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.0884   -0.4126    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.5178    0.4125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2325    0.8251    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5178   -0.4126    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2325    1.6504    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.9471    0.4125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6617    0.8251    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.9471   -0.4126    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.3764    0.4125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2325   -0.8252    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7898   -0.3034    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2015    0.4116    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  3  1  0
  2  4  1  6
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  2  9  1  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
  3 13  2  0
  3 14  1  0
 14 15  1  0
 15 16  1  1
 15 17  1  0
 17 18  1  0
 17 19  1  6
 18 20  1  0
 16 21  1  0
 16 22  2  0
 21 23  1  0
 23 24  1  6
 23 25  1  0
 25 26  1  0
 25 27  1  1
 24 28  2  0
 24 29  1  0
 29 30  1  0
 30 31  1  0
 30 32  1  1
 31 33  1  0
 31 34  2  0
 33 35  1  0
 35 36  1  0
 35 37  1  6
 36 38  2  0
 36 39  1  0
 39 40  1  0
 39 41  2  0
 40 42  1  0
 37 43  1  0
 44 42  1  0
 44 45  1  0
 42 45  1  0
M  END

Associated Targets(non-human)

SUB1 Subtilisin-like protease (110 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 625.77Molecular Weight (Monoisotopic): 625.3799AlogP: -1.74#Rotatable Bonds: 20
Polar Surface Area: 237.92Molecular Species: BASEHBA: 9HBD: 8
#RO5 Violations: 2HBA (Lipinski): 15HBD (Lipinski): 9#RO5 Violations (Lipinski): 3
CX Acidic pKa: 11.61CX Basic pKa: 10.19CX LogP: -1.80CX LogD: -4.24
Aromatic Rings: Heavy Atoms: 44QED Weighted: 0.06Np Likeness Score: 0.10

References

1. Lidumniece E, Withers-Martinez C, Hackett F, Blackman MJ, Jirgensons A..  (2022)  Subtilisin-like Serine Protease 1 (SUB1) as an Emerging Antimalarial Drug Target: Current Achievements in Inhibitor Discovery.,  65  (19.0): [PMID:36137276] [10.1021/acs.jmedchem.2c01093]

Source